Enteral lactoferrin supplementation for prevention of sepsis and necrotizing enterocolitis in preterm infants

坏死性小肠结肠炎 乳铁蛋白 肠内给药 败血症 医学 小肠结肠炎 重症监护医学 内科学 肠外营养 生物 遗传学
作者
Mohan Pammi,Kanekal Suresh Gautham
出处
期刊:The Cochrane library [Elsevier]
被引量:111
标识
DOI:10.1002/14651858.cd007137.pub6
摘要

Background Lactoferrin, a normal component of human colostrum and milk, can enhance host defenses and may be effective for prevention of sepsis and necrotizing enterocolitis (NEC) in preterm neonates. Objectives To assess the safety and effectiveness of lactoferrin supplementation to enteral feeds for prevention of sepsis and NEC in preterm neonates. Secondarily, we assessed the effects of lactoferrin supplementation to enteral feeds on the duration of positive‐pressure ventilation, development of chronic lung disease (CLD) or periventricular leukomalacia (PVL), length of hospital stay to discharge among survivors, and adverse neurological outcomes at two years of age or later. Search methods We used the standard search strategy of Cochrane Neonatal to update our search. We searched the Cochrane Central Register of Controlled Trials (CENTRAL 2019, Issue 9), MEDLINE via PubMed (1966 to 20 January 2020), PREMEDLINE (1996 to 20 January 2020), Embase (1980 to 20 January 2020), and CINAHL (1982 to 20 January 2020). We also searched clinical trials databases, conference proceedings, and the reference lists of retrieved articles for randomized controlled trials and quasi‐randomized trials. Selection criteria In our search, we included randomized controlled trials (RCTs) evaluating enteral lactoferrin supplementation at any dose or duration to prevent sepsis or NEC in preterm neonates. Data collection and analysis We used the standard methods of Cochrane Neonatal and the GRADE approach to assess the certainty of evidence. Main results Meta‐analysis of data from twelve randomized controlled trials showed that lactoferrin supplementation to enteral feeds decreased suspected or confirmed late‐onset sepsis (typical RR 0.80, 95% CI 0.72 to 0.89; typical RD ‐0.05, 95% CI, ‐0.07 to ‐0.02; NNTB 20, 95% CI 14 to 50; 12 studies, 5425 participants, low‐certainty evidence) and decreased length of hospital stay (MD ‐2.38 to 95% CI, ‐4.67 to ‐0.09; 3 studies, 1079 participants, low‐certainty evidence). A subgroup analysis including data of infants with confirmed sepsis demonstrates a decrease in confirmed late‐onset sepsis (typical RR 0.83, 95% CI 0.73 to 0.94; typical RD ‐0.03, 95% CI, ‐0.04 to ‐0.01; NNTB 33, 95% CI 25 to 100; 12 studies, 5425 participants, low‐certainty evidence). Sensitivity analysis including only good methodological certainty studies suggested a decrease in late‐onset sepsis (both suspected and confirmed) with enteral lactoferrin supplementation (typical RR 0.82, 95% CI, 0.74 to 0.91; typical RD ‐0.04, 95% CI, ‐0.06 to ‐0.02; NNTB 20, 95% CI 14 to 50; 9 studies, 4702 participants, low‐certainty evidence). There were no differences in NEC stage II or III (typical RR 1.10, 95% CI, 0.86 to 1.41; typical RD ‐0.00, 95% CI, ‐0.02 to 0.01; 7 studies, 4874 participants; low‐certainty evidence) or 'all‐cause mortality' (typical RR 0.90, 95% CI 0.69 to 1.17; typical RD ‐0.00, 95% CI, ‐0.01 to 0.01; 11 studies, 5510 participants; moderate‐certainty evidence). One study reported no differences in neurodevelopmental testing by Mullen's or Bayley III at 24 months of age after enteral lactoferrin supplementation (one study, 292 participants, low‐certainty evidence). Lactoferrin supplementation to enteral feeds with probiotics decreased late‐onset sepsis (RR 0.25, 95% CI 0.14 to 0.46; RD ‐0.13, 95% CI ‐0.18 to ‐0.08; NNTB 8, 95% CI 6 to 13; 3 studies, 564 participants; low‐certainty evidence) and NEC stage II or III (RR 0.04, 95% CI 0.00 to 0.62; RD ‐0.05, 95% CI ‐0.08 to ‐0.03; NNTB 20, 95% CI 12.5 to 33.3; 1 study, 496 participants; very low‐certainty evidence), but not 'all‐cause mortality' (very low‐certainty evidence). Lactoferrin supplementation to enteral feeds with or without probiotics had no effect on CLD, duration of mechanical ventilation or threshold retinopathy of prematurity (low‐certainty evidence). Investigators reported no adverse effects in the included studies. Authors' conclusions We found low‐certainty evidence from studies of good methodological quality that lactoferrin supplementation of enteral feeds decreases late‐onset sepsis (both suspected and confirmed, and confirmed only) but not NEC ≥ stage II or 'all cause mortality' or neurodevelopmental outcomes at 24 months of age in preterm infants without adverse effects. Low‐ to very low‐certainty evidence suggests that lactoferrin supplementation of enteral feeds in combination with probiotics decreases late‐onset sepsis (data from confirmed sepsis only) and NEC ≥ stage II in preterm infants without adverse effects, however, there were few included studies of poor methodological quality. The presence of publication bias and small studies of poor methodology that may inflate the effect size make recommendations for clinical practice difficult.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
PDF的下载单位、IP信息已删除 (2025-6-4)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
老逗完成签到,获得积分20
1秒前
帅气驳回了yar应助
1秒前
2秒前
汉堡包应助科研通管家采纳,获得10
2秒前
yar应助科研通管家采纳,获得10
2秒前
传奇3应助科研通管家采纳,获得10
3秒前
慕青应助科研通管家采纳,获得10
3秒前
打打应助科研通管家采纳,获得10
3秒前
爆米花应助科研通管家采纳,获得10
3秒前
科目三应助科研通管家采纳,获得30
3秒前
科研通AI2S应助科研通管家采纳,获得10
3秒前
3秒前
pp发布了新的文献求助10
3秒前
NexusExplorer应助book采纳,获得10
4秒前
4秒前
怕黑誉完成签到,获得积分10
6秒前
6秒前
JCao727完成签到,获得积分10
6秒前
7秒前
hhhh完成签到 ,获得积分10
7秒前
温柔梦易发布了新的文献求助10
8秒前
8秒前
小二郎应助易逢春采纳,获得10
10秒前
10秒前
zhouz发布了新的文献求助10
11秒前
11秒前
嘉子发布了新的文献求助10
12秒前
李健的粉丝团团长应助MrDI采纳,获得10
13秒前
bkagyin应助SUN采纳,获得10
14秒前
楼楼楼发布了新的文献求助30
14秒前
bei发布了新的文献求助10
14秒前
清秀成威发布了新的文献求助30
14秒前
善学以致用应助淦淦采纳,获得10
15秒前
16秒前
1111完成签到,获得积分10
16秒前
河豚关注了科研通微信公众号
16秒前
17秒前
pp完成签到,获得积分10
18秒前
19秒前
高分求助中
Picture Books with Same-sex Parented Families: Unintentional Censorship 700
ACSM’s Guidelines for Exercise Testing and Prescription, 12th edition 500
Nucleophilic substitution in azasydnone-modified dinitroanisoles 500
不知道标题是什么 500
Indomethacinのヒトにおける経皮吸収 400
Phylogenetic study of the order Polydesmida (Myriapoda: Diplopoda) 370
Effective Learning and Mental Wellbeing 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 冶金 细胞生物学 免疫学
热门帖子
关注 科研通微信公众号,转发送积分 3975375
求助须知:如何正确求助?哪些是违规求助? 3519700
关于积分的说明 11199305
捐赠科研通 3256034
什么是DOI,文献DOI怎么找? 1798049
邀请新用户注册赠送积分活动 877386
科研通“疑难数据库(出版商)”最低求助积分说明 806305